Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zentalis Pharmaceuticals Inc (NQ: ZNTL ) 4.522 +0.542 (+13.61%) Streaming Delayed Price Updated: 3:18 PM EDT, Jul 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zentalis Pharmaceuticals Inc < Previous 1 2 3 Next > Wall Street's Top 10 Stock Calls This Week - Saturday, June 22 June 22, 2024 What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of June 17-21, 2024. Via Talk Markets (ZNTL) - Analyzing Zentalis Pharma's Short Interest June 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 20, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 19, 2024 Via Benzinga Analyst Expectations for Zentalis Pharma's Future November 07, 2023 Via Benzinga Where Zentalis Pharma Stands With Analysts August 10, 2023 Via Benzinga Analyst Expectations for Zentalis Pharma's Future June 07, 2023 Via Benzinga Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 18, 2024 Via Benzinga Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday? June 18, 2024 Zentalis Pharmaceuticals announced the FDA's partial clinical hold on azenosertib studies due to recent patient deaths. Via Benzinga Exposures Product Safety Zentalis Gears Up for Phase 3 Study of Azenosertib after Positive Phase 1b Outcomes May 26, 2023 Via Benzinga Where Zentalis Pharma Stands With Analysts May 19, 2023 Via Benzinga Zentalis Pharma: Q1 Earnings Insights May 10, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 18, 2024 Via Benzinga ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 ZNTL stock results show that Zentalis Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session March 28, 2024 Via Benzinga MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential February 22, 2024 MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months. Via Talk Markets Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform January 08, 2024 From Immunome, Inc. Via Business Wire Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know November 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 06, 2023 Via Benzinga TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday November 06, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga Topics Stocks Exposures US Equities Around $108M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying June 21, 2023 Although US stocks closed lower on Tuesday, there were a few notable insider trades. Via Benzinga 5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More June 15, 2023 Via Benzinga Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday June 15, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to... Via Benzinga Why Shares of Zentalis Pharmaceuticals Dropped This Week June 02, 2023 A rash of insider selling meant the stock gave back some of its gains from last week. Via The Motley Fool Stocks That Hit 52-Week Lows On Friday March 10, 2023 On Friday, 497 companies set new 52-week lows. Via Benzinga Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL) January 10, 2023 From Newman Ferrara LLP Via Business Wire 4 Analysts Have This to Say About Zentalis Pharmaceuticals November 11, 2022 Zentalis Pharmaceuticals (NASDAQ:ZNTL) has observed the following analyst ratings within the last quarter: Via Benzinga Oppenheimer Maintains Outperform Rating for Zentalis Pharmaceuticals: Here's What You Need To Know November 10, 2022 Oppenheimer has decided to maintain its Outperform rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) and lower its price target from $80.00 to $50.00. Shares of Zentalis Pharmaceuticals are trading up... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.